chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Itching on left arm of vaccine; Swelling on arm of vaccine; Sore arm on left side; Redness on arm on arm of vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching on left arm of vaccine), VACCINATION SITE SWELLING (Swelling on arm of vaccine), VACCINATION SITE PAIN (Sore arm on left side) and VACCINATION SITE ERYTHEMA (Redness on arm on arm of vaccine) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Itchy skin.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching on left arm of vaccine), VACCINATION SITE SWELLING (Swelling on arm of vaccine), VACCINATION SITE PAIN (Sore arm on left side) and VACCINATION SITE ERYTHEMA (Redness on arm on arm of vaccine). At the time of the report, VACCINATION SITE PRURITUS (Itching on left arm of vaccine) and VACCINATION SITE SWELLING (Swelling on arm of vaccine) had not resolved and VACCINATION SITE PAIN (Sore arm on left side) and VACCINATION SITE ERYTHEMA (Redness on arm on arm of vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included cream for itchy skin.  No treatment medication was reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Decreased appetite, Diarrhoea, Mobility decreased
Clinical narrative: felt like she had Covid; injection site was hot to touch; she couldn't raise her arm above her head; weakness; loss of appetite; diarrhea; fever; body aches; vomiting; her joints hurt for about a week; injection site was swollen; injection site was red; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (felt like she had Covid), VACCINATION SITE WARMTH (injection site was hot to touch), MOBILITY DECREASED (she couldn't raise her arm above her head), ASTHENIA (weakness) and DECREASED APPETITE (loss of appetite) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetic and Blood pressure high.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced SUSPECTED COVID-19 (felt like she had Covid), VACCINATION SITE WARMTH (injection site was hot to touch), MOBILITY DECREASED (she couldn't raise her arm above her head), ASTHENIA (weakness), DECREASED APPETITE (loss of appetite), DIARRHOEA (diarrhea), PYREXIA (fever), MYALGIA (body aches), VOMITING (vomiting), ARTHRALGIA (her joints hurt for about a week), VACCINATION SITE SWELLING (injection site was swollen) and VACCINATION SITE ERYTHEMA (injection site was red). At the time of the report, SUSPECTED COVID-19 (felt like she had Covid), VACCINATION SITE WARMTH (injection site was hot to touch), MOBILITY DECREASED (she couldn't raise her arm above her head), ASTHENIA (weakness), DECREASED APPETITE (loss of appetite), DIARRHOEA (diarrhea), PYREXIA (fever), MYALGIA (body aches), VOMITING (vomiting), ARTHRALGIA (her joints hurt for about a week), VACCINATION SITE SWELLING (injection site was swollen) and VACCINATION SITE ERYTHEMA (injection site was red) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Nov-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was reported.  No treatment details was provided.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow-up received on 10-MAY-2021 and events outcome was updated to resolved. On 22-Jul-2021: No New Information added.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, SARS-CoV-2 test, Suspected COVID-19, Vaccination site erythema
Clinical narrative: felt like she had Covid; injection site was hot to touch; she couldn't raise her arm above her head; weakness; loss of appetite; diarrhea; fever; body aches; vomiting; her joints hurt for about a week; injection site was swollen; injection site was red; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (felt like she had Covid), VACCINATION SITE WARMTH (injection site was hot to touch), MOBILITY DECREASED (she couldn't raise her arm above her head), ASTHENIA (weakness) and DECREASED APPETITE (loss of appetite) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetic and Blood pressure high.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced SUSPECTED COVID-19 (felt like she had Covid), VACCINATION SITE WARMTH (injection site was hot to touch), MOBILITY DECREASED (she couldn't raise her arm above her head), ASTHENIA (weakness), DECREASED APPETITE (loss of appetite), DIARRHOEA (diarrhea), PYREXIA (fever), MYALGIA (body aches), VOMITING (vomiting), ARTHRALGIA (her joints hurt for about a week), VACCINATION SITE SWELLING (injection site was swollen) and VACCINATION SITE ERYTHEMA (injection site was red). At the time of the report, SUSPECTED COVID-19 (felt like she had Covid), VACCINATION SITE WARMTH (injection site was hot to touch), MOBILITY DECREASED (she couldn't raise her arm above her head), ASTHENIA (weakness), DECREASED APPETITE (loss of appetite), DIARRHOEA (diarrhea), PYREXIA (fever), MYALGIA (body aches), VOMITING (vomiting), ARTHRALGIA (her joints hurt for about a week), VACCINATION SITE SWELLING (injection site was swollen) and VACCINATION SITE ERYTHEMA (injection site was red) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Nov-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was reported.  No treatment details was provided.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow-up received on 10-MAY-2021 and events outcome was updated to resolved. On 22-Jul-2021: No New Information added.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth, Vomiting
Clinical narrative: felt like she had Covid; injection site was hot to touch; she couldn't raise her arm above her head; weakness; loss of appetite; diarrhea; fever; body aches; vomiting; her joints hurt for about a week; injection site was swollen; injection site was red; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (felt like she had Covid), VACCINATION SITE WARMTH (injection site was hot to touch), MOBILITY DECREASED (she couldn't raise her arm above her head), ASTHENIA (weakness) and DECREASED APPETITE (loss of appetite) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetic and Blood pressure high.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced SUSPECTED COVID-19 (felt like she had Covid), VACCINATION SITE WARMTH (injection site was hot to touch), MOBILITY DECREASED (she couldn't raise her arm above her head), ASTHENIA (weakness), DECREASED APPETITE (loss of appetite), DIARRHOEA (diarrhea), PYREXIA (fever), MYALGIA (body aches), VOMITING (vomiting), ARTHRALGIA (her joints hurt for about a week), VACCINATION SITE SWELLING (injection site was swollen) and VACCINATION SITE ERYTHEMA (injection site was red). At the time of the report, SUSPECTED COVID-19 (felt like she had Covid), VACCINATION SITE WARMTH (injection site was hot to touch), MOBILITY DECREASED (she couldn't raise her arm above her head), ASTHENIA (weakness), DECREASED APPETITE (loss of appetite), DIARRHOEA (diarrhea), PYREXIA (fever), MYALGIA (body aches), VOMITING (vomiting), ARTHRALGIA (her joints hurt for about a week), VACCINATION SITE SWELLING (injection site was swollen) and VACCINATION SITE ERYTHEMA (injection site was red) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Nov-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was reported.  No treatment details was provided.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow-up received on 10-MAY-2021 and events outcome was updated to resolved. On 22-Jul-2021: No New Information added.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain
Clinical narrative: sore at the injection site; tender at the injection site; red at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red at the injection site), VACCINATION SITE PAIN (sore at the injection site) and VACCINATION SITE PAIN (tender at the injection site) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     The patient's past medical history included Shingles. Concomitant products included PARACETAMOL (TYLENOL), LEVOTHYROXINE SODIUM (SYNTHROID), OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) and GUAIFENESIN (MUCINEX) for an unknown indication.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (red at the injection site). On an unknown date, the patient experienced VACCINATION SITE PAIN (sore at the injection site) and VACCINATION SITE PAIN (tender at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (red at the injection site), VACCINATION SITE PAIN (sore at the injection site) and VACCINATION SITE PAIN (tender at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash, Rash erythematous, Rash pruritic
Clinical narrative: Arm a little bit sore; Red rash; A little bit itchy; Bumpy rash all over the trunk of her body; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm a little bit sore), RASH ERYTHEMATOUS (Red rash), RASH PRURITIC (A little bit itchy) and RASH (Bumpy rash all over the trunk of her body) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol, Pain and Shingles (patient thought she had a shingles episode). Concomitant products included SIMVASTATIN for Cholesterol, GABAPENTIN for Pain, VALACYCLOVIR [VALACICLOVIR] for Shingles, LEVOTHYROXINE and TRAMADOL for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm a little bit sore), RASH ERYTHEMATOUS (Red rash), RASH PRURITIC (A little bit itchy) and RASH (Bumpy rash all over the trunk of her body). On 19-Mar-2021, PAIN IN EXTREMITY (Arm a little bit sore) had resolved. At the time of the report, RASH ERYTHEMATOUS (Red rash), RASH PRURITIC (A little bit itchy) and RASH (Bumpy rash all over the trunk of her body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was provided for events.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: COVID-19 infection; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (COVID-19 infection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced COVID-19 (COVID-19 infection). At the time of the report, COVID-19 (COVID-19 infection) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not reported.  Treatment medication was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Blister, Glossodynia, Lip swelling, Swollen tongue, Vaccination site rash
Clinical narrative: Tongue is swollen; tongue very sensitive when eating with blisters around the edges; tongue very sensitive when eating with blisters around the edges; a swollen lower lip; Covid-arm rash at the site of the injection down to her elbow; This spontaneous case was reported by a consumer and describes the occurrence of SWOLLEN TONGUE (Tongue is swollen), GLOSSODYNIA (tongue very sensitive when eating with blisters around the edges), BLISTER (tongue very sensitive when eating with blisters around the edges), LIP SWELLING (a swollen lower lip) and VACCINATION SITE RASH (Covid-arm rash at the site of the injection down to her elbow) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced SWOLLEN TONGUE (Tongue is swollen), GLOSSODYNIA (tongue very sensitive when eating with blisters around the edges), BLISTER (tongue very sensitive when eating with blisters around the edges), LIP SWELLING (a swollen lower lip) and VACCINATION SITE RASH (Covid-arm rash at the site of the injection down to her elbow). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 04-Mar-2021 for Adverse event, at an unspecified dose and frequency. On 18-Mar-2021, VACCINATION SITE RASH (Covid-arm rash at the site of the injection down to her elbow) had resolved. On 28-Mar-2021, SWOLLEN TONGUE (Tongue is swollen), BLISTER (tongue very sensitive when eating with blisters around the edges) and LIP SWELLING (a swollen lower lip) had resolved. At the time of the report, GLOSSODYNIA (tongue very sensitive when eating with blisters around the edges) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.   This case was linked to MOD-2021-120025 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: Reporter details, patient demographics and event information updated
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: hives; This spontaneous case was reported by a patient and describes the occurrence of URTICARIA (hives) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030l20a and 031m20a) for COVID-19 vaccination.     The patient's past medical history included Tumour (painful tumor on face) in December 2020. Concomitant products included METFORMIN, GLICLAZIDE, COLCHICINE and LISINOPRIL for an unknown indication.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient experienced URTICARIA (hives). At the time of the report, URTICARIA (hives) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication was reported.   This case was linked to MOD-2021-059555 (Patient Link).
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Dyspnoea, Fatigue
Clinical narrative: shortness of oxygen; headaches; positive Covid test; loss of taste; loss of smell; head congestion; throat hurt; fatigue; This spontaneous case was reported by a patient and describes the occurrence of OROPHARYNGEAL PAIN (throat hurt), HEAD DISCOMFORT (head congestion), AGEUSIA (loss of taste), ANOSMIA (loss of smell) and COVID-19 (positive Covid test) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Fatigue. Concomitant products included LEVOTHYROXINE for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced FATIGUE (fatigue). On 26-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (throat hurt). On 27-Feb-2021, the patient experienced HEAD DISCOMFORT (head congestion). On 02-Mar-2021, the patient experienced AGEUSIA (loss of taste) and ANOSMIA (loss of smell). On 03-Mar-2021, the patient experienced COVID-19 (positive Covid test). On 08-Mar-2021, the patient experienced HEADACHE (headaches). On 18-Mar-2021, the patient experienced DYSPNOEA (shortness of oxygen). On 27-Feb-2021, OROPHARYNGEAL PAIN (throat hurt) had resolved. On 13-Mar-2021, HEAD DISCOMFORT (head congestion) had resolved. At the time of the report, AGEUSIA (loss of taste) and COVID-19 (positive Covid test) was resolving, ANOSMIA (loss of smell), DYSPNOEA (shortness of oxygen) and HEADACHE (headaches) had not resolved and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication was reported.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort, Headache, Oropharyngeal pain
Clinical narrative: shortness of oxygen; headaches; positive Covid test; loss of taste; loss of smell; head congestion; throat hurt; fatigue; This spontaneous case was reported by a patient and describes the occurrence of OROPHARYNGEAL PAIN (throat hurt), HEAD DISCOMFORT (head congestion), AGEUSIA (loss of taste), ANOSMIA (loss of smell) and COVID-19 (positive Covid test) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Fatigue. Concomitant products included LEVOTHYROXINE for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced FATIGUE (fatigue). On 26-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (throat hurt). On 27-Feb-2021, the patient experienced HEAD DISCOMFORT (head congestion). On 02-Mar-2021, the patient experienced AGEUSIA (loss of taste) and ANOSMIA (loss of smell). On 03-Mar-2021, the patient experienced COVID-19 (positive Covid test). On 08-Mar-2021, the patient experienced HEADACHE (headaches). On 18-Mar-2021, the patient experienced DYSPNOEA (shortness of oxygen). On 27-Feb-2021, OROPHARYNGEAL PAIN (throat hurt) had resolved. On 13-Mar-2021, HEAD DISCOMFORT (head congestion) had resolved. At the time of the report, AGEUSIA (loss of taste) and COVID-19 (positive Covid test) was resolving, ANOSMIA (loss of smell), DYSPNOEA (shortness of oxygen) and HEADACHE (headaches) had not resolved and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication was reported.
Sex: F
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: redness on my arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness on my arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (redness on my arm). At the time of the report, ERYTHEMA (redness on my arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pyrexia, Rash, Vaccination site erythema
Clinical narrative: head to toe rash; a red solid band of 4 inches wide on the injection site and on the back which is also very itchy; a red solid band of 4 inches wide, then it appeared on the injection site and on the back; a red solid band of 4 inches wide,then it appeared on injection site and on the back; felt tired; body aches; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), VACCINATION SITE REACTION (a red solid band of 4 inches wide, then it appeared on the injection site and on the back), RASH (head to toe rash), VACCINATION SITE PRURITUS (a red solid band of 4 inches wide on the injection site and on the back which is also very itchy) and PYREXIA (fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced PAIN (body aches) and PYREXIA (fever). On 20-Mar-2021, the patient experienced FATIGUE (felt tired). On 21-Mar-2021, the patient experienced VACCINATION SITE REACTION (a red solid band of 4 inches wide, then it appeared on the injection site and on the back). 21-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (a red solid band of 4 inches wide on the injection site and on the back which is also very itchy) and VACCINATION SITE ERYTHEMA (a red solid band of 4 inches wide,then it appeared on injection site and on the back). On 22-Mar-2021, the patient experienced RASH (head to toe rash). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, PAIN (body aches), VACCINATION SITE REACTION (a red solid band of 4 inches wide, then it appeared on the injection site and on the back), RASH (head to toe rash), VACCINATION SITE PRURITUS (a red solid band of 4 inches wide on the injection site and on the back which is also very itchy), PYREXIA (fever), FATIGUE (felt tired) and VACCINATION SITE ERYTHEMA (a red solid band of 4 inches wide,then it appeared on injection site and on the back) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications information was reported.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    This case was linked to MOD-2021-059084 (Patient Link).
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site reaction
Clinical narrative: head to toe rash; a red solid band of 4 inches wide on the injection site and on the back which is also very itchy; a red solid band of 4 inches wide, then it appeared on the injection site and on the back; a red solid band of 4 inches wide,then it appeared on injection site and on the back; felt tired; body aches; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), VACCINATION SITE REACTION (a red solid band of 4 inches wide, then it appeared on the injection site and on the back), RASH (head to toe rash), VACCINATION SITE PRURITUS (a red solid band of 4 inches wide on the injection site and on the back which is also very itchy) and PYREXIA (fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced PAIN (body aches) and PYREXIA (fever). On 20-Mar-2021, the patient experienced FATIGUE (felt tired). On 21-Mar-2021, the patient experienced VACCINATION SITE REACTION (a red solid band of 4 inches wide, then it appeared on the injection site and on the back). 21-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (a red solid band of 4 inches wide on the injection site and on the back which is also very itchy) and VACCINATION SITE ERYTHEMA (a red solid band of 4 inches wide,then it appeared on injection site and on the back). On 22-Mar-2021, the patient experienced RASH (head to toe rash). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, PAIN (body aches), VACCINATION SITE REACTION (a red solid band of 4 inches wide, then it appeared on the injection site and on the back), RASH (head to toe rash), VACCINATION SITE PRURITUS (a red solid band of 4 inches wide on the injection site and on the back which is also very itchy), PYREXIA (fever), FATIGUE (felt tired) and VACCINATION SITE ERYTHEMA (a red solid band of 4 inches wide,then it appeared on injection site and on the back) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications information was reported.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    This case was linked to MOD-2021-059084 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Illness, Limb discomfort, Nausea
Clinical narrative: barely move her arm; felt sick; extreme chills; low grade fever; fatigue; nausea; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (barely move her arm), ILLNESS (felt sick), CHILLS (extreme chills), PYREXIA (low grade fever) and FATIGUE (fatigue) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (barely move her arm), ILLNESS (felt sick), CHILLS (extreme chills), PYREXIA (low grade fever), FATIGUE (fatigue) and NAUSEA (nausea). At the time of the report, LIMB DISCOMFORT (barely move her arm), ILLNESS (felt sick), CHILLS (extreme chills), PYREXIA (low grade fever), FATIGUE (fatigue) and NAUSEA (nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Nov-2020, SARS-CoV-2 test positive: positive (Positive) mild symptoms, low fever, dry cough, headache, and loss of smell/taste.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product were not provided.  Treatment medication were not reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: barely move her arm; felt sick; extreme chills; low grade fever; fatigue; nausea; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (barely move her arm), ILLNESS (felt sick), CHILLS (extreme chills), PYREXIA (low grade fever) and FATIGUE (fatigue) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (barely move her arm), ILLNESS (felt sick), CHILLS (extreme chills), PYREXIA (low grade fever), FATIGUE (fatigue) and NAUSEA (nausea). At the time of the report, LIMB DISCOMFORT (barely move her arm), ILLNESS (felt sick), CHILLS (extreme chills), PYREXIA (low grade fever), FATIGUE (fatigue) and NAUSEA (nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Nov-2020, SARS-CoV-2 test positive: positive (Positive) mild symptoms, low fever, dry cough, headache, and loss of smell/taste.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product were not provided.  Treatment medication were not reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discolouration, Vaccination site pruritus
Clinical narrative: turning dark pink color big circle around that area; arm started itching at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (turning dark pink color big circle around that area) and VACCINATION SITE PRURITUS (arm started itching at the injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     Concomitant products included MULTIVITAMIN [VITAMINS NOS], ATORVASTATIN and ATENOLOL for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE DISCOLOURATION (turning dark pink color big circle around that area) and VACCINATION SITE PRURITUS (arm started itching at the injection site). At the time of the report, VACCINATION SITE DISCOLOURATION (turning dark pink color big circle around that area) and VACCINATION SITE PRURITUS (arm started itching at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medicines were  not reported.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Pruritus, Rash, Urticaria
Clinical narrative: Extraordinarily burning pain; Itchiness all over body; Rash; Couple of hives; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Extraordinarily burning pain), PRURITUS (Itchiness all over body), RASH (Rash) and URTICARIA (Couple of hives) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included DROSPIRENONE, ETHINYLESTRADIOL (GIANVI) for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced BURNING SENSATION (Extraordinarily burning pain), PRURITUS (Itchiness all over body), RASH (Rash) and URTICARIA (Couple of hives). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, BURNING SENSATION (Extraordinarily burning pain), RASH (Rash) and URTICARIA (Couple of hives) had resolved and PRURITUS (Itchiness all over body) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Antibody test negative
Clinical narrative: No Antibodies detected (lack of efficacy); This spontaneous case was reported by a pharmacist and describes the occurrence of ANTIBODY TEST NEGATIVE (No Antibodies detected (lack of efficacy)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ANTIBODY TEST NEGATIVE (No Antibodies detected (lack of efficacy)). At the time of the report, ANTIBODY TEST NEGATIVE (No Antibodies detected (lack of efficacy)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hypokinesia, Myalgia, Neck pain, Pain in extremity
Clinical narrative: Arm is still very sore; Can barely turn my head; Neck pain; Chills; Low fever; Back muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm is still very sore), HYPOKINESIA (Can barely turn my head), NECK PAIN (Neck pain), CHILLS (Chills) and PYREXIA (Low fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Recovered in two weeks without medical intervention.) on 03-Jan-2021.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced PAIN IN EXTREMITY (Arm is still very sore), HYPOKINESIA (Can barely turn my head), NECK PAIN (Neck pain), CHILLS (Chills), PYREXIA (Low fever) and MYALGIA (Back muscle pain). In March 2021, CHILLS (Chills) and PYREXIA (Low fever) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm is still very sore), HYPOKINESIA (Can barely turn my head), NECK PAIN (Neck pain) and MYALGIA (Back muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Arm is still very sore; Can barely turn my head; Neck pain; Chills; Low fever; Back muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm is still very sore), HYPOKINESIA (Can barely turn my head), NECK PAIN (Neck pain), CHILLS (Chills) and PYREXIA (Low fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Recovered in two weeks without medical intervention.) on 03-Jan-2021.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced PAIN IN EXTREMITY (Arm is still very sore), HYPOKINESIA (Can barely turn my head), NECK PAIN (Neck pain), CHILLS (Chills), PYREXIA (Low fever) and MYALGIA (Back muscle pain). In March 2021, CHILLS (Chills) and PYREXIA (Low fever) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm is still very sore), HYPOKINESIA (Can barely turn my head), NECK PAIN (Neck pain) and MYALGIA (Back muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: Physician suggested to wait for second dose, she did not receive second dose; chills; fever; muscle pain, aches; Joint pain; fatigue; nausea; headache; This spontaneous case was reported by a consumer and describes the occurrence of OFF LABEL USE (Physician suggested to wait for second dose, she did not receive second dose), CHILLS (chills), PYREXIA (fever), MYALGIA (muscle pain, aches) and ARTHRALGIA (Joint pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced CHILLS (chills), PYREXIA (fever), MYALGIA (muscle pain, aches), ARTHRALGIA (Joint pain), FATIGUE (fatigue), NAUSEA (nausea) and HEADACHE (headache). On an unknown date, the patient experienced OFF LABEL USE (Physician suggested to wait for second dose, she did not receive second dose). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, OFF LABEL USE (Physician suggested to wait for second dose, she did not receive second dose) outcome was unknown, CHILLS (chills), PYREXIA (fever), ARTHRALGIA (Joint pain), FATIGUE (fatigue), NAUSEA (nausea) and HEADACHE (headache) was resolving and MYALGIA (muscle pain, aches) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment medication did not help. The patient felt like she was hit by a truck. As of 21-Mar-2021, the patient woke up in the morning feeling better but she still has aches.   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Lot number and event information updated
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Off label use, Pyrexia
Clinical narrative: Physician suggested to wait for second dose, she did not receive second dose; chills; fever; muscle pain, aches; Joint pain; fatigue; nausea; headache; This spontaneous case was reported by a consumer and describes the occurrence of OFF LABEL USE (Physician suggested to wait for second dose, she did not receive second dose), CHILLS (chills), PYREXIA (fever), MYALGIA (muscle pain, aches) and ARTHRALGIA (Joint pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced CHILLS (chills), PYREXIA (fever), MYALGIA (muscle pain, aches), ARTHRALGIA (Joint pain), FATIGUE (fatigue), NAUSEA (nausea) and HEADACHE (headache). On an unknown date, the patient experienced OFF LABEL USE (Physician suggested to wait for second dose, she did not receive second dose). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, OFF LABEL USE (Physician suggested to wait for second dose, she did not receive second dose) outcome was unknown, CHILLS (chills), PYREXIA (fever), ARTHRALGIA (Joint pain), FATIGUE (fatigue), NAUSEA (nausea) and HEADACHE (headache) was resolving and MYALGIA (muscle pain, aches) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment medication did not help. The patient felt like she was hit by a truck. As of 21-Mar-2021, the patient woke up in the morning feeling better but she still has aches.   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Lot number and event information updated
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: an itchy, red, raised rash at the injection site; an itchy, red, raised rash at the injection site; an itchy, red, raised rash at the injection site; Headache; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE PRURITUS (an itchy, red, raised rash at the injection site), VACCINATION SITE ERYTHEMA (an itchy, red, raised rash at the injection site), VACCINATION SITE RASH (an itchy, red, raised rash at the injection site) and HEADACHE (Headache) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (an itchy, red, raised rash at the injection site), VACCINATION SITE ERYTHEMA (an itchy, red, raised rash at the injection site), VACCINATION SITE RASH (an itchy, red, raised rash at the injection site) and HEADACHE (Headache). At the time of the report, VACCINATION SITE PRURITUS (an itchy, red, raised rash at the injection site), VACCINATION SITE ERYTHEMA (an itchy, red, raised rash at the injection site), VACCINATION SITE RASH (an itchy, red, raised rash at the injection site) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal swelling, Swelling face, Urticaria
Clinical narrative: Hives in the face and throat; Swelling in the face; Swelling in the throat; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives in the face and throat), SWELLING FACE (Swelling in the face) and PHARYNGEAL SWELLING (Swelling in the throat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives in the face and throat), SWELLING FACE (Swelling in the face) and PHARYNGEAL SWELLING (Swelling in the throat). At the time of the report, URTICARIA (Hives in the face and throat), SWELLING FACE (Swelling in the face) and PHARYNGEAL SWELLING (Swelling in the throat) outcome was unknown.    No concomitant medications were provided. Treatment medications were unknown. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash, Rash erythematous, Vaccination site reaction
Clinical narrative: Itchy skin; Red rash; Painful rash; Rash which migrated to top of his biceps and side of the injection site; very intense at the injection site/near rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (very intense at the injection site/near rash), PRURITUS (Itchy skin), RASH ERYTHEMATOUS (Red rash), RASH (Painful rash) and RASH (Rash which migrated to top of his biceps and side of the injection site) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced VACCINATION SITE REACTION (very intense at the injection site/near rash). On 17-Mar-2021, the patient experienced RASH ERYTHEMATOUS (Red rash), RASH (Painful rash) and RASH (Rash which migrated to top of his biceps and side of the injection site). On an unknown date, the patient experienced PRURITUS (Itchy skin). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, VACCINATION SITE REACTION (very intense at the injection site/near rash), PRURITUS (Itchy skin), RASH ERYTHEMATOUS (Red rash), RASH (Painful rash) and RASH (Rash which migrated to top of his biceps and side of the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   This case was linked to MOD-2021-163283, MOD-2021-163283   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow up  received on 25 May 2021 and updated reporter information and event. On 23-Jul-2021: follow up received , email address was added.
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: warm at the injection site; large red spot at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (warm at the injection site) and INJECTION SITE ERYTHEMA (large red spot at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced INJECTION SITE WARMTH (warm at the injection site) and INJECTION SITE ERYTHEMA (large red spot at the injection site). At the time of the report, INJECTION SITE WARMTH (warm at the injection site) and INJECTION SITE ERYTHEMA (large red spot at the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  No treatment medication was reported.